TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance

Virchows Archiv

Volumn 466, Issue 5, 2015, Pages 525-532

  Miao, Zhi Feng ^a   Wang, Zhen Ning ^a   Zhao, Ting Ting ^a   Xu, Ying Ying ^a   Wu, Jian Hua ^a   Liu, Xing Yu ^a   Xu, Hao ^a   You, Yi ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chemoresistance; Gastric cancer; Proliferation; TRIM24

Indexed keywords

CARRIER PROTEIN; SMALL INTERFERING RNA; TRIM24 PROTEIN, HUMAN;

ADENOCARCINOMA; AGED; CELL PROLIFERATION; DRUG RESISTANCE; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH TUMOR; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; AGED; BLOTTING, WESTERN; CARRIER PROTEINS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION; UP-REGULATION;

EID: 84937511212     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-015-1737-4     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
2. Brenner H, Rothenbacher D, Arndt V (2009) Epidemiology of stomach cancer. Methods Mol Biol 472:467–477
3. Jia B, Liu H, Kong Q, Li B (2012) RKIP expression associated with gastric cancer cell invasion and metastasis. Tumour Biol 33(4):919–925
4. Jia Y, Dong B, Tang L, Liu Y, Du H, Yuan P, Wu A, Ji J (2012) Apoptosis index correlates with chemotherapy efficacy and predicts the survival of patients with gastric cancer. Tumour Biol 33(4):1151–1158
5. Oishi Y, Watanabe Y, Yoshida Y, Sato Y, Hiraishi T, Oikawa R, Maehata T, Suzuki H, Toyota M, Niwa H, Suzuki M, Itoh F (2012) Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer. Tumour Biol 33(2):383–393
6. Le Douarin B, Nielsen AL, Garnier JM, Ichinose H, Jeanmougin F, Losson R, Chambon P (1996) A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J 15(23):6701–6715
7. Le Douarin B, Nielsen AL, You J, Chambon P, Losson R (1997) TIF1 alpha: a chromatin-specific mediator for the ligand-dependent activation function AF-2 of nuclear receptors? Biochem Soc Trans 25(2):605–612
8. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat P, Heery D, Gronemeyer H, Chambon P, Losson R (1995) The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14(9):2020–2033
9. Klugbauer S, Rabes HM (1999) The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 18(30):4388–4393
10. Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, Zhang H, Kalantry S, Freedman LP, Pandolfi PP (1999) A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat Genet 23(3):287–295
11. Belloni E, Trubia M, Gasparini P, Micucci C, Tapinassi C, Confalonieri S, Nuciforo P, Martino B, Lo-Coco F, Pelicci PG, Di Fiore PP (2005) 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes. Genes Chromosomes Cancer 42(3):320–325
12. Katzenellenbogen BS (1996) Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 54(2):287–293
13. Tsai WW, Wang Z, Yiu TT, Akdemir KC, Xia W, Winter S, Tsai CY, Shi X, Schwarzer D, Plunkett W, Aronow B, Gozani O, Fischle W, Hung MC, Patel DJ, Barton MC (2010) TRIM24 links a non-canonical histone signature to breast cancer. Nature 468(7326):927–932
14. Chambon M, Orsetti B, Berthe ML, Bascoul-Mollevi C, Rodriguez C, Duong V, Gleizes M, Thenot S, Bibeau F, Theillet C, Cavailles V (2011) Prognostic significance of TRIM24/TIF-1alpha gene expression in breast cancer. Am J Pathol 178(4):1461–1469
15. Li H, Sun L, Tang Z, Fu L, Xu Y, Li Z, Luo W, Qiu X, Wang E (2012) Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer. PLoS One 7(5):e37657
16. Zhang LH, Yin AA, Cheng JX, Huang HY, Li XM, Zhang YQ, Han N, and Zhang X (2015) TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway. Oncogene 34:600–610
17. Jeong SH, Ko GH, Cho YH, Lee YJ, Cho BI, Ha WS, Choi SK, Kim JW, Lee CW, Heo YS, Shin SH, Yoo J, Hong SC (2012) Pyrophosphatase overexpression is associated with cell migration, invasion, and poor prognosis in gastric cancer. Tumour Biol 33(6):1889–1898
18. Yu HF, Zhao G, Ge ZJ, Wang DR, Chen J, Zhang Y, Zha TZ, Zhang K, Zhang M, Tan YF, Zhou SJ, Jiang C (2012) High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma. Tumour Biol 33(5):1557–1563
19. Xie C, Fu L, Han Y, Li Q, Wang E (2014) Decreased ARID1A expression facilitates cell proliferation and inhibits 5-fluorouracil-induced apoptosis in colorectal carcinoma. Tumour Biol 35:7921–7792
20. Yothaisong S, Dokduang H, Techasen A, Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ, Loilome W (2013) Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Tumour Biol 34(6):3637–3648
21. Shin JY, Kim JO, Lee SK, Chae HS, Kang JH (2010) LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein–Barr virus-positive gastric cancer cells. BMC Cancer 10:425